Conditional gp130-JAK-STAT3 activation induces malignant transformation in vivo

被引：0
|
作者：
Scherger, A. K. [1 ]
Schick, M. [1 ]
Steiger, K. [2 ]
Al-Maarri, M. [3 ]
Wunderlich, F. T. [3 ]
Rose-John, S. [4 ]
Peschel, C. [1 ]
Keller, U. [1 ]
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, Med Dept 3, Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Inst Pathol, Munich, Germany
[3] Max Planck Inst Metab Res, Cologne, Germany
[4] Christian Albrechts Univ Kiel, Inst Biochem, Kiel, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2017年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P294
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [1] Constitutive gp130-JAK-STAT3 signaling induces a plasma cell malignancy featuring all characteristics of human myeloma - a novel in vivo myeloma model for a patient subgroup with STAT3 activation
    Steidle, S.
    Dechow, T.
    Goetze, K.
    Rudelius, M.
    Kratzat, S.
    Behnke, K.
    Pechloff, K.
    Bullinger, L.
    Fend, F.
    Mitova, N.
    Li, Z.
    Thaler, M.
    Bauer, J.
    Pietschmann, E.
    Albers, C.
    Grundler, R.
    Ruland, J.
    Peschel, C.
    Duyster, J.
    Rose-John, S.
    Bassermann, F.
    Keller, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 192 - 192
  • [2] Constitutive gp130-JAK-STAT3 Signaling Induces a Plasma Cell Disorder Representing Genetic and Clinical Features of Human Myeloma - a Novel in Vivo Model for the Patient Subgroup Characterized By a STAT3 Target Gene Signature
    Steidle, Sabine
    Dechow, Tobias
    Goetze, Katharina
    Rudelius, Martina
    Pechloff, Konstanze
    Behnke, Kerstin
    Bullinger, Lars
    Fend, Falko
    Valeria, Soberon
    Schmidt-Supprian, Marc
    Bassermann, Florian
    Ruland, Juergen
    Peschel, Christian
    Keller, Ulrich
    BLOOD, 2014, 124 (21)
  • [3] gp130 activation induces a unique form of cardiac myocyte hypertrophy via JAK1 and STAT activation
    Oi, M
    Stankus, G
    Hawkins, E
    Perrone, M
    Clark, K
    Merkel, L
    FASEB JOURNAL, 1999, 13 (04): : A439 - A439
  • [4] Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt-β-catenin-mediated intestinal tumor growth and regeneration
    Phesse, Toby J.
    Buchert, Michael
    Stuart, Emma
    Flanagan, Dustin J.
    Faux, Maree
    Afshar-Sterle, Shoukat
    Walker, Francesca
    Zhang, Hui-Hua
    Nowell, Cameron J.
    Jorissen, Robert
    Tan, Chin Wee
    Hirokawa, Yumiko
    Eissmann, Moritz F.
    Poh, Ashleigh R.
    Malaterre, Jordane
    Pearson, Helen B.
    Kirsch, David G.
    Provero, Paolo
    Poli, Valeria
    Ramsay, Robert G.
    Sieber, Oliver
    Burgess, Antony W.
    Huszar, Dennis
    Vincan, Elizabeth
    Ernst, Matthias
    SCIENCE SIGNALING, 2014, 7 (345) : ra92
  • [5] Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting
    Zanders, Lukas
    Kny, Melanie
    Hahn, Alexander
    Schmidt, Sibylle
    Wundersitz, Sebastian
    Todiras, Mihail
    Lahmann, Ines
    Bandyopadhyay, Arnab
    Wollersheim, Tobias
    Kaderali, Lars
    Luft, Friedrich C.
    Birchmeier, Carmen
    Weber-Carstens, Steffen
    Fielitz, Jens
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2022, 13 (01) : 713 - 727
  • [6] STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo
    Pietrangelo, Antonello
    Dierssen, Uta
    Valli, Linda
    Garuti, Cinzia
    Rump, Agrani
    Corradini, Elena
    Ernst, Matthias
    Klein, Christian
    Trautwein, Christian
    GASTROENTEROLOGY, 2007, 132 (01) : 294 - 300
  • [7] Langat virus inhibits the gp130/JAK/STAT signaling by reducing the gp130 protein level
    Lin, Shaoli
    Wang, Xiaochun
    Sallapalli, Bhargava Teja
    Hage, Adam
    Chang, Peixi
    He, Jia
    Best, Sonja M.
    Zhang, Yanjin
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (04)
  • [8] Internalization of the interleukin 6 signal transducer gp130 does not require activation of the Jak/STAT pathway
    Thiel, S
    Behrmann, I
    Dittrich, E
    Muys, L
    Tavernier, J
    Wijdenes, J
    Heinrich, PC
    Graeve, L
    BIOCHEMICAL JOURNAL, 1998, 330 : 47 - 54
  • [9] Activating mutations of the gp130/JAK/STAT pathway in human diseases
    Lokau, Juliane
    Garbers, Christoph
    INTRACELLULAR SIGNALLING PROTEINS, 2019, 116 : 283 - 309
  • [10] Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes
    Kunisada, K
    Hirota, H
    Fujio, Y
    Matsui, H
    Tani, Y
    YamauchiTakihara, K
    Kishimoto, T
    CIRCULATION, 1996, 94 (10) : 2626 - 2632
12345